Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.

PCCA's own Sebastian Denison to speak on the LDN Radio Show on February 20th, at 3 p.m. CT!

Mike and Seb had a tremendous January, meeting with industry leaders Dr. Pamela Wartian Smith, Saad Dinno, and Bryan Prescott. You can connect to the best pharmacy compounding podcast on the web right here!

Late last year, we were excited to debut PermE8™ Anhydrous Gel, a new compounding base that holds a lot of potential for compounding pharmacies and their patients, especially when it comes to pain management.

We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.

By Maria Carvalho, PharmD, MRPharmS, PhD. She is the Manager of PCCA Science.

International Seminar is the largest event in the pharmacy compounding industry. Every year, it’s where we get to do one of the things we find most exciting: introduce compounders to new products that can help them meet their patients’ needs and operate their pharmacies more efficiently. Today was no exception. This morning, we introduced International Seminar attendees to some exciting new products, including three pharmaceutical bases and an innovative pharmacy management software.